Jeffrey A. Cohen - Concepedia

Author

Jeffrey A. Cohen

Cleveland Clinic ORCID

Also Known As

Cohen, Jeffrey, J A Cohen, J COHEN, J Cohen, J. A. COHEN, J. A. Cohen, J. Cohen, J. Kaufman, J.A. COHEN, J.A. Cohen

618

Publications

31.6K

Citations

H-Index

169

Concepts

All Affiliations

Cleveland Clinic University of Pennsylvania University of California, San Francisco Case Western Reserve University McGill University

About

Jeffrey A. Cohen is an author at Cleveland Clinic specializing in medicine, neurology, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	43	14.5K
2	Health Sciences	8	8	10.7K
3	Public Health	2	2	97
4	Engineering	1	1	203
5	Natural Sciences	1	1	90

Jeffrey A. Cohen

140

Publications

22.4K

Citations

H-Index

Page 1

	Year	Citations
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria Chris H. Polman, Stephen C. Reingold, Brenda Banwell, Annals of Neurology Mcdonald CriteriaNeurological DisorderMedicineNeuroepidemiologyDiagnostic Criterion	2011	9.7K
Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics M C Raff, ER Abney, Jeffrey A. Cohen, Journal of Neuroscience	1983	759
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Vincent Dousset, Robert I. Grossman, Karen Ramer, Radiology Neurological DisorderWhite MatterImmunologyMagnetic ResonanceExperimental Allergic Encephalomyelitis	1992	693
Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls Myla Goldman, Ruth Ann Marrie, Jeffrey A. Cohen Multiple Sclerosis Journal	2007	656
Sympathetic skin response--a method of assessing unmyelinated axon dysfunction in peripheral neuropathies. Bhagwan T. Shahani, John Halperin, P. Boulu, Journal of Neurology Neurosurgery & Psychiatry Peripheral Nerve InjuryNeurological DisorderPeripheral NerveDermatologyPeripheral Nerves	1984	599
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation David B. Weiner, Jing Liu, Jeffrey A. Cohen, Nature Signal TransductionNeu Oncogene MimicsG Protein-coupled ReceptorFunctional SelectivityReceptor (Biochemistry)	1989	427
Benefit of interferon β-1a on MSFC progression in secondary progressive MS Jeffrey A. Cohen, Gary Cutter, Jill S. Fischer, Neurology	2002	403
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis Robert W. Motl, Jeffrey A. Cohen, Ralph H. B. Benedict, Multiple Sclerosis Journal	2017	393
Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia Ashish Jain, Chi Adrian, Shiyung Liu, Nature Immunology Specific Missense MutationsMendelian DisorderNemo ResultGenetic DisorderGenetics	2001	392
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial Ludwig Kappos, Krzysztof Selmaj, Amit Bar‐Or, The Lancet Neurology Clinical TrialsTreatment OptionPharmacotherapyNeurologyMultiple Sclerosis	2019	276

Page 1